SCHEMBL7757907

SCHEMBL7757907

O=C(NO)C1=CC=CC(=S(=O)=O)C1CC1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 8/20 0.36
HDAC1 Q13547 7/20 0.32
HDAC3 O15379 2/20 0.32
HDAC2 Q92769 2/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
CA9 Q16790 1/20 0.31
HDAC8 Q9BY41 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
ALOX15 P16050 1/20 0.30
ALOX12 P18054 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762129 0.85 EPHX2 (0.30)
SCHEMBL17483892 0.56 HDAC6 (0.70) HDAC6HDAC1HDAC3HDAC2CA2
SCHEMBL31054194 0.56
Bicarbonate SCHEMBL3901610 0.54 LMNA (0.43) CA12CA1CA2MMP1MMP2
Methane SCHEMBL28254634 0.53 ALOX5 (0.44) CA12CA1CA2MMP1MMP2
Methane SCHEMBL20679777 0.53 CHRM5 (0.41) MEN1KMT2A
SCHEMBL20535887 0.53 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC8
Urea SCHEMBL27625501 0.53 ALOX5 (0.52) CA12CA1CA2MMP1MMP2
SCHEMBL4179368 0.52 KMT2A (0.63) HDAC6HDAC1HDAC3HDAC2CA12
SCHEMBL4179001 0.52 KMT2A (0.63) HDAC6HDAC1HDAC3HDAC2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098662-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2001-05-16 EP claimed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO claimed
EP-1098662-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2001-05-16 EP disclosed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO disclosed